ZETROZ SYSTEMS LLC

Trumbull, CT · Medtech · Private

Wireless long-duration low-intensity ultrasound sonophoresis device with NSAID enhancement for transdermal drug delivery in osteoarthritis pain management

Grants
$19M
19 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$1000K
1 award · Defense
#319 of 4531 in medtech
Patents
13
2 granted · 11 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Defense · Phase I · Hydrogel-based Long-duration ultrasound wound dressing to enhance cellular regeneration and rapid wound closure$149,997
Federal grantDepartment of Health and Human Services · Phase II · Self Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations$1,200,000
Federal contractDepartment of Defense · Igf::ot::igf. Dhp Phase II STTR Entitled "innovative Wound Regeneration Support Approaches To Enable Rapid Treatment Of Wounded Warfighters".$999,979
Federal grantDepartment of Health and Human Services · Phase II · Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations$268,958
Federal grantDepartment of Health and Human Services · Phase II · Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations$400,000
Federal grantDepartment of Health and Human Services · Phase II · Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations$400,000
Federal grantDepartment of Health and Human Services · Phase I · Daily and localized NSAID sonophoresis for symptomatic treatment of knee osteoarthritis$224,176
Federal grantDepartment of Health and Human Services · Phase I · Daily and localized NSAID sonophoresis for symptomatic treatment of knee osteoarthritis$223,719
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain$217,772
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain$451,369
Federal grantDepartment of Health and Human Services · Phase II · Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis$1,442,543
Federal grantDepartment of Health and Human Services · Phase II · Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis$1,427,916
Federal grantDepartment of Health and Human Services · Phase I · Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain$233,597
Federal grantDepartment of Health and Human Services · Phase II · Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis$1,438,616
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase II · Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain$1,482,405
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase II · Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain$1,482,405
Federal grantDepartment of Health and Human Services · Phase II · Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain$1,578,495
Federal grantDepartment of Health and Human Services · Phase II · Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis$2,196,474
Federal grantDepartment of Health and Human Services · Phase II · Clinical Optimization of Ultrasonic Drug Delivery Technologies for US Veteran Populations that Experience Health Disparities with Arthritis and Chronic Pain$1,457,643
Federal grantDepartment of Health and Human Services · Phase II · Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis$2,359,304
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
316inNOveta Biomedical LLC$1.0M—
317Carrera Bioscience Inc.$1.0M—
318BIOWAVE CORP$1.0M$1.7M
319ZETROZ SYSTEMS LLC$1000K—
320Caregility Corp$997K$7.5M
321ARETE BIOSCIENCES$995K—
322CROSSLIFE TECHNOLOGIES INC.$966K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 13
  • High Density Ultrasound Coupling Gel And Methods Of Use Thereofapplication
  • Wireless Ultrasound Devicegranted
  • Low-profile, Low-frequency, And Low-impedance Broad-band Ultrasound Transducer And Methods Thereofgranted
  • Flexible And Wearable Long Duration Ultrasound Deviceapplication
  • Ultrasound Coupling Patch With Gel Capture Featureapplication
  • Limited Use Ultrasonic Coupling Deviceapplication
  • Ultrasound Coupling Patch With Gel Capture Featureapplication
  • Fleixble And Wearable Long Duration Ultrasound Deviceapplication
  • Low-profile Ultrasound Transducer With Dose Monitoring And Adaptive Regulationapplication
  • Ultrasound Coupling Gel And Patch For Improved Thermal, Drug Delivery And Long Duration Ultrasound Treatmentapplication
  • Low-profile Ultrasound Transducer With Dose Monitoring And Adaptive Regulationapplication
  • Ultrasound Transducer Arrayapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.